/ /

  • linkedin
  • Increase Font
  • Sharebar

    Ebola and the eye

    Managing ophthalmic manifestations of virus heightens screening, treatment protocols


    Steven Yeh, MD, with a physician performing an indirect exam on patients at the Lunsar Baptist Eye Clinic in Port Loko District, Sierra Leone. (Image courtesy of Jessica G. Shantha, MD)

    Ocular symptoms present

    Dr. Crozier, who had been working in an Ebola treatment unit in Sierra Leone, was treated for 40 days then discharged when blood and urine tests for the virus were negative. But 14 weeks after his initial diagnosis, he developed ocular symptoms.

    As his condition worsened, Dr. Yeh and Jessica G. Shantha, MD from the Emory Eye Center, along with infectious disease physicians from the Emory University Hospital Serious Communicable Diseases Unit, intervened with procedures including a paracentesis of the anterior chamber.

    More from this author: IRIS Registry may do more than improve patient outcomes

    “That led to the identification of live Ebola virus in the eye both by culture and also by molecular testing,” Dr. Yeh said.

    Dr. Crozier was treated with a combination of oral, topical, and local corticosteroids and an oral antiviral medication. His symptoms improved over several months, and he subsequently has returned to Liberia and Sierra Leone to continue his volunteer work with Ebola survivors.

    Managing ocular complications

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results